Structure Therapeutics Cash Flow Statement 2021-2024 | GPCR

Fifteen years of historical annual cash flow statements for Structure Therapeutics (GPCR).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021
$-89.62$-51.32$-38.05
$-5.68$-0.63$0.15
$8.85$2.86$1.68
$3.17$2.23$1.83
$0$0$0
$0$0$0
$-0.86$2.15$1.90
$-4.34$-0.73$-1.25
$6.97$2.97$4.06
$-79.49$-46.12$-32.16
$-2.17$-0.16$-1.21
$0$0$0
$0$0$0
$-266.18$-61.95$19.07
$0$0$0
$-266.18$-61.95$19.07
$0$0$0
$-268.34$-62.11$17.86
$0$0$0
$0$0$0
$0$0$0
$173$0.03$0.01
$173$31.53$103
$0$0$0
$278$-2.51$0
$452$29.01$103
$104$-79.21$88.95
$8.19$2.51$1.49
$0$0$0